Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
DNA polymerase III
', a new form of
DNA polymerase III
, has been purified 15,000-fold to 90% homogeneity from an Escherichia coli K12 strain.
DNA polymerase III
's is a subassembly of four subunits of the
DNA polymerase III
holoenzyme; it has functional and physical properties intermediate between the core
DNA polymerase III
and holoenzyme.
Polyacrylamide
gel electrophoresis performed under denaturing conditions indicates
DNA polymerase III
' to be a complex of the alpha, epsilon, and theta subunits of
DNA polymerase III
and a newly assigned subunit of the
DNA polymerase III
holoenzyme, tau (Mr = 83,000). Both gel filtration and phosphocellulose chromatography separate
DNA polymerase III
from
DNA polymerase III
'. All enzyme forms can utilize a duplex template containing short gaps.
DNA polymerase III
', like the
DNA polymerase III
holoenzyme, can synthesize DNA on a long single-stranded template in the presence of 5 mM spermidine;
DNA polymerase III
cannot. Alone,
DNA polymerase III
' is inert in the G4 natural replicative system in which the
DNA polymerase III
holoenzyme is active. Molecular weight and subunit stoichiometry determinations suggest that
DNA polymerase III
' contains two units of core
DNA polymerase III
and two tau subunits.
...
PMID:Purification and characterization of DNA polymerase III'. Identification of tau as a subunit of the DNA polymerase III holoenzyme. 703 70
Harnessing CRISPR-Cas9 technology provides an unprecedented ability to modify genomic loci via DNA double-strand break (DSB) induction and repair. We analyzed nonhomologous end-joining (NHEJ) repair induced by Cas9 in budding yeast and found that the orientation of binding of Cas9 and its guide RNA (gRNA) profoundly influences the pattern of insertion/deletions (indels) at the site of cleavage. A common indel created by Cas9 is a 1-bp (+1) insertion that appears to result from Cas9 creating a 1-nt 5' overhang that is filled in by a
DNA polymerase
and ligated. The origin of +1 insertions was investigated by using two gRNAs with
PAM
sequences located on opposite DNA strands but designed to cleave the same sequence. These templated +1 insertions are dependent on the X-family
DNA polymerase
, Pol4. Deleting Pol4 also eliminated +2 and +3 insertions, which are biased toward homonucleotide insertions. Using inverted
PAM
sequences, we also found significant differences in overall NHEJ efficiency and repair profiles, suggesting that the binding of the Cas9:gRNA complex influences subsequent NHEJ processing. As with events induced by the site-specific HO endonuclease, CRISPR-Cas9-mediated NHEJ repair depends on the Ku heterodimer and DNA ligase 4. Cas9 events are highly dependent on the Mre11-Rad50-Xrs2 complex, independent of Mre11's nuclease activity. Inspection of the outcomes of a large number of Cas9 cleavage events in mammalian cells reveals a similar templated origin of +1 insertions in human cells, but also a significant frequency of similarly templated +2 insertions.
...
PMID:CRISPR/Cas9 cleavages in budding yeast reveal templated insertions and strand-specific insertion/deletion profiles. 2978 87
<< Previous
1
2